Background Small cell lung cancer (SCLC) is a chemotherapy‐responsive tumor type but
most patients ultimately experience disease progression. SCLC is associated with …

Background. A positive influence of anticoagulant treatment in small cell lung cancer (SCLC)
has been sug gested by experimental and clinical data. Methods. In a multicenter clinical …

Purpose Venous thromboembolism (VTE) is common in cancer patients. Evidence has
suggested that low molecular weight heparin (LMWH) might improve survival in patients with …

The Cancer and Leukemia Group B (CALGB) conducted a prospective randomized trial to
evaluate the role of warfarin and alternating chemotherapy in extensive small-cell lung …

OBJECTIVE To prospectively assess whether low-molecular-weight heparin (LMWH)
provides a survival benefit in patients with advanced cancer. PATIENTS AND METHODS …

Abstract Learning Objectives After completing this course, the reader will be able to: Define
characteristics of the interface between deep vein thrombosis and malignancy. Evaluate …

Background: Low‐molecular‐weight heparins (LMWH) have an antitumor effect in vitro and
in experimental animal models of malignancy. Retrospective data suggest that it might …

Background Tumors may exploit the coagulation system to enhance the survival and
dissemination of cancer cells. Some studies have suggested that heparin and low molecular …

PURPOSE Studies by the Veterans Administration Cooperative Studies Program and
Cancer and Leukemia Group B (CALGB) suggested that the addition of warfarin to …

Background Cancer cells rely on angiogenesis for growth and dissemination, and small cell
lung cancer (SCLC) is a highly angiogenic tumor. We evaluated thalidomide, an anti …